Skip to main content
Fig. 2 | Malaria Journal

Fig. 2

From: Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties

Fig. 2

Effect of Terminalia albida treatment on survival, weight and cerebral symptoms in ECM model. C57BL/6 mice were infected with P. berghei ANKA and treated 2 h later with chloroquine (5 mg/kg), Terminalia albida crude extract (100 mg/kg) or water (25 mL/kg) from Day 0 to Day 4. a Percentage of survival. b Percentage of weight loss at each day compared to Day 0. c Rapid murine cerebral behavior scale (RMCBS) between D3 and D7. *P < 0.05 compared Terminalia albida to H2O groups at D7. *P < 0.05 and **P < 0.005 compared Terminalia albida to H2O groups. §P < 0.05 compared Terminalia albida to chloroquine groups

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us